HMG CoA reductase expression as a prognostic factor in Korean patients with breast cancer: A retrospective study

There are many preclinical and epidemiological reports suggesting a correlation between 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoAR) or HMG-CoAR inhibitor (statin) treatment and prognosis in breast cancer. This study aimed to investigate the expression of HMG-CoAR in Korean patients wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Kim, Hyojeong, Seol, Young Mi, Choi, Young Jin, Shin, Ho-Jin, Chung, Joo Seop, Shin, Nari, Kim, Ahrong, Kim, Jee Yeon, Kim, Keun Young, Bae, Youngtae
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6456116/
https://ncbi.nlm.nih.gov/pubmed/30921201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000014968
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados